In this study, we demonstrated that cells from CML patients with the VSELs phenotype (LVSELs) similarly harbor the fusion protein BCR-ABL and are less sensitive to apoptosis than leukemic HSCs after IM treatment. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.